| Literature DB >> 28509281 |
Tomoyuki Yamazaki1, Tetsu Akimoto2, Yoshitaka Iwazu1, Taro Sugase1, Eri Takeshima1, Akihiko Numata1, Takanori Komada1, Hiromichi Yoshizawa1, Naoko Otani1, Yoshiyuki Morishita1, Osamu Saito1, Fumi Takemoto1, Shigeaki Muto1, Eiji Kusano1, Daisuke Nagata1.
Abstract
Bleeding from the gastrointestinal tract is one of the common determinants of morbidity and mortality in the ordinary clinical setting. The gastrointestinal involvement of Henoch-Schönlein purpura (HSP) has often been described as self-limiting, with no long-term morbidity. In this report, we describe our experience with a male HSP patient who presented with abdominal pain, loss of appetite and deteriorated renal function associated with nephrotic syndrome. Despite the use of aggressive immunomodulatory treatments, including corticosteroids and plasmapheresis, he developed lethal gastrointestinal hemorrhage. We believe that the accumulation of more experience with additional cases similar to ours is mandatory for the establishment of optimal management for HSP patients with severe gastrointestinal manifestations.Entities:
Keywords: Entecavir; Gastrointestinal bleeding; Henoch–Schönlein purpura; Human albumin scintigraphy; Leukocytoclastic vasculitis
Year: 2014 PMID: 28509281 PMCID: PMC5411628 DOI: 10.1007/s13730-014-0148-8
Source DB: PubMed Journal: CEN Case Rep ISSN: 2192-4449